Axiom Advisory LLC Increases Stock Position in The Procter & Gamble Company (NYSE:PG)

Axiom Advisory LLC lifted its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 83.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 112,384 shares of the company’s stock after buying an additional 51,282 shares during the period. Axiom Advisory LLC’s holdings in Procter & Gamble were worth $19,081,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the second quarter worth $29,000. Ruedi Wealth Management Inc. boosted its position in Procter & Gamble by 64.7% during the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after purchasing an additional 77 shares in the last quarter. POM Investment Strategies LLC acquired a new stake in Procter & Gamble in the second quarter valued at $34,000. Finally, Transcendent Capital Group LLC purchased a new position in shares of Procter & Gamble in the fourth quarter valued at $31,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Down 1.1 %

NYSE PG opened at $167.07 on Tuesday. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a fifty-two week low of $141.60 and a fifty-two week high of $177.94. The business has a 50 day moving average price of $171.15 and a two-hundred day moving average price of $166.55. The stock has a market cap of $394.31 billion, a PE ratio of 27.30, a P/E/G ratio of 3.73 and a beta of 0.41.

Procter & Gamble (NYSE:PG) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The company’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the company earned $1.37 earnings per share. As a group, sell-side analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Analyst Ratings Changes

PG has been the subject of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. BNP Paribas initiated coverage on Procter & Gamble in a research report on Monday, June 24th. They issued an “outperform” rating and a $187.00 price objective on the stock. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research report on Friday. Finally, Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and cut their target price for the company from $182.00 to $175.00 in a research note on Wednesday, July 24th. Nine analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $175.89.

Insider Activity

In other news, insider Balaji Purushothaman sold 8,842 shares of Procter & Gamble stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the transaction, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now owns 13,072 shares in the company, valued at approximately $2,212,043.84. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is currently owned by corporate insiders.

About Procter & Gamble

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.